94 related articles for article (PubMed ID: 23789962)
21. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
[TBL] [Abstract][Full Text] [Related]
22. The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats.
Liu S; Wu HJ; Zhang ZQ; Chen Q; Liu B; Wu JP; Zhu L
Eur J Pharmacol; 2011 Jan; 650(1):384-9. PubMed ID: 20965162
[TBL] [Abstract][Full Text] [Related]
23. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
Endo M; Masaki T; Seike M; Yoshimatsu H
Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
[TBL] [Abstract][Full Text] [Related]
24. Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism.
Pan HJ; Lin Y; Chen YE; Vance DE; Leiter EH
Vascul Pharmacol; 2006 Jul; 45(1):65-71. PubMed ID: 16750656
[TBL] [Abstract][Full Text] [Related]
25. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
26. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.
Inoue M; Ohtake T; Motomura W; Takahashi N; Hosoki Y; Miyoshi S; Suzuki Y; Saito H; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2005 Oct; 336(1):215-22. PubMed ID: 16125673
[TBL] [Abstract][Full Text] [Related]
28. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
29. Anti-obesity effects of Geranium thunbergii extract via improvement of lipid metabolism in high-fat diet-induced obese mice.
Sung YY; Yoon T; Yang WK; Kim SJ; Kim HK
Mol Med Rep; 2011; 4(6):1107-13. PubMed ID: 21874243
[TBL] [Abstract][Full Text] [Related]
30. The influence of methionine, selenomethionine, and vitamin E on liver metabolic pathways and steatosis in high-cholesterol fed rabbits.
Birkner E; Zalejska-Fiolka J; Kasperczyk A; Kasperczyk S; Grucka-Mamczar E; Stawiarska-Pieta B; Birkner K
Biol Trace Elem Res; 2007; 120(1-3):179-94. PubMed ID: 17916970
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease.
Jung JH; Kim HS
Food Chem Toxicol; 2013 Oct; 60():404-12. PubMed ID: 23900008
[TBL] [Abstract][Full Text] [Related]
32. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
[TBL] [Abstract][Full Text] [Related]
33. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
34. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
37. Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
Lee YS; Cha BY; Choi SS; Choi BK; Yonezawa T; Teruya T; Nagai K; Woo JT
J Nutr Biochem; 2013 Jan; 24(1):156-62. PubMed ID: 22898571
[TBL] [Abstract][Full Text] [Related]
38. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
Ezquer M; Ezquer F; Ricca M; Allers C; Conget P
J Hepatol; 2011 Nov; 55(5):1112-20. PubMed ID: 21356258
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study.
Rull A; Geeraert B; Aragonès G; Beltrán-Debón R; Rodríguez-Gallego E; García-Heredia A; Pedro-Botet J; Joven J; Holvoet P; Camps J
J Proteome Res; 2014 Mar; 13(3):1731-43. PubMed ID: 24479691
[TBL] [Abstract][Full Text] [Related]
40. Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
Yang SJ; Choi JM; Chae SW; Kim WJ; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Kim SW; Park CY
PLoS One; 2011 Feb; 6(2):e17057. PubMed ID: 21373642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
